Charles A. Sanders, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,333 shares at $26.66 ($89K) on 2008-05-27, disclosed to the SEC on 2008-05-28.
Scheduled sale ($89k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.40 | 333 | $9K | 9.9% |
| 2 | $26.54 | 334 | $9K | 9.9% |
| 3 | $26.66 | 334 | $9K | 10.0% |
| 4 | $26.68 | 666 | $18K | 19.9% |
| 5 | $26.71 | 333 | $9K | 10.0% |
| 6 | $26.75 | 333 |
| $9K |
| 10.0% |
| 7 | $26.84 | 334 | $9K | 10.1% |
| 8 | $26.99 | 333 | $9K | 10.1% |
| 9 | $27.16 | 333 | $9K | 10.1% |
| Total | $26.74 avg | 3,333 | $89K | 100% |
| Filing → |
| BIOD | BUY | 2011-08-11 | $12K | — | Filing → |
| BIOD | BUY | 2010-05-13 | $28K | — | Filing → |
| BCRX | BUY | 2010-02-09 | $33K | — | Filing → |